LundaGUARD - A Consortium For Fighting Infectious Agents

A new consortium aimed at leveraging the partners ́ platforms for accelerated structure-based drug discovery towards a “weak spot” in the Sars-CoV-2 virus replication machinery, the NSP10 protein.